Zurich Cantonal Bank Portfolio holdings
AUM
$40.9B
1-Year Return
22.88%
This Quarter Return
+13.6%
1 Year Return
+22.88%
3 Year Return
+106.76%
5 Year Return
+189.8%
10 Year Return
+428.78%
AUM
$26.1B
AUM Growth
+$3.46B
(+15%)
Cap. Flow
+$741M
Cap. Flow
% of AUM
2.84%
Top 10 Holdings %
Top 10 Hldgs %
29.84%
Holding
2,836
New
42
Increased
1,472
Reduced
668
Closed
101
Top Buys
| 1 |
Amazon
AMZN
|
$137M |
| 2 |
Broadcom
AVGO
|
$134M |
| 3 |
UBS Group
UBS
|
$119M |
| 4 |
Logitech
LOGI
|
$72M |
| 5 |
Bank of New York Mellon
BK
|
$49M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$101M |
| 2 |
Booking.com
BKNG
|
$57.9M |
| 3 |
Alcon
ALC
|
$54.5M |
| 4 |
Lowe's Companies
LOW
|
$47.1M |
| 5 |
Aflac
AFL
|
$43M |
Sector Composition
| 1 | Technology | 27.85% |
| 2 | Financials | 16.4% |
| 3 | Healthcare | 14% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
MacroGenics
MGNX
$126M
| $19.2K | ﹤0.01% |
1,997
-253
| -11% | -$2.43K |
|
2602
Dole
DOLE
$1.29B
| $18.5K | ﹤0.01% |
1,506
| – | – |
|
2603
Grifois
GRFS
$6.89B
| $18.5K | ﹤0.01% |
1,597
-201
| -11% | -$2.32K |
|
2604
Mural Oncology
MURA
$35.9M
| $17.4K | ﹤0.01% |
+2,936
| New | +$17.4K |
|
2605
Immunocore
IMCR
$1.87B
| $16.6K | ﹤0.01% |
243
-30
| -11% | -$2.05K |
|
2606
Wallbox
WBX
$67.2M
| $16.4K | ﹤0.01% |
474
-418
| -47% | -$14.5K |
|
2607
HUTCHMED
HCM
$2.74B
| $15.9K | ﹤0.01% |
878
-112
| -11% | -$2.03K |
|
2608
Codexis
CDXS
$218M
| $15.9K | ﹤0.01% |
5,208
-412
| -7% | -$1.26K |
|
2609
Mesa Laboratories
MLAB
$356M
| $15.5K | ﹤0.01% |
148
| – | – |
|
2610
iShares Russell 2000 ETF
IWM
$67.8B
| $15.1K | ﹤0.01% |
74
| – | – |
|
2611
Sanofi
SNY
$113B
| $14.9K | ﹤0.01% |
300
-65
| -18% | -$3.23K |
|
2612
Ascendis Pharma
ASND
$12.5B
| $13.9K | ﹤0.01% |
110
-14
| -11% | -$1.76K |
|
2613
Fulcrum Therapeutics
FULC
$414M
| $13.7K | ﹤0.01% |
2,023
| – | – |
|
2614
Cricut
CRCT
$1.26B
| $12.7K | ﹤0.01% |
1,932
| – | – |
|
2615
Pluri
PLUR
$39.5M
| $12.6K | ﹤0.01% |
2,720
-222
| -8% | -$1.03K |
|
2616
News Corp Class B
NWS
$18.8B
| $12K | ﹤0.01% |
+467
| New | +$12K |
|
2617
Personalis
PSNL
$465M
| $10.9K | ﹤0.01% |
5,190
-423
| -8% | -$888 |
|
|
ONC
2618
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $10.8K | ﹤0.01% |
60
-7
| -10% | -$1.26K |
|
2619
Traeger
COOK
$200M
| $10.4K | ﹤0.01% |
3,802
| – | – |
|
|
VRNA
2620
Verona Pharma
VRNA
$9.2B
| $10.4K | ﹤0.01% |
521
-66
| -11% | -$1.31K |
|
2621
Genmab
GMAB
$16.9B
| $10.2K | ﹤0.01% |
320
-41
| -11% | -$1.31K |
|
|
BCYC
2622
Bicycle Therapeutics
BCYC
$496M
| $8.28K | ﹤0.01% |
458
-56
| -11% | -$1.01K |
|
2623
SPDR S&P 500 ETF Trust
SPY
$660B
| $6.19K | ﹤0.01% |
13
| – | – |
|
2624
Sangamo Therapeutics
SGMO
$165M
| $5.51K | ﹤0.01% |
10,137
-817
| -7% | -$444 |
|
2625
LivePerson
LPSN
$89.9M
| $5.18K | ﹤0.01% |
1,366
-8,313
| -86% | -$31.5K |
|